Brompheniramine, codeine, and phenylephrine and Insulin glargine and lixisenatide
Determining the interaction of Brompheniramine, codeine, and phenylephrine and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brompheniramine / codeine / phenylephrine
Brand name: M-End PE, Poly-Tussin AC, TL-Hist CD
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brompheniramine, codeine, and phenylephrine-Insulin glargine and lixisenatide Subcutaneous
- Brompheniramine, codeine, and phenylephrine-Insulin glargine, recombinant Subcutaneous
- Brompheniramine, codeine, and phenylephrine-Insulin glulisine
- Brompheniramine, codeine, and phenylephrine-Insulin Glulisine (Cartridges and Pens)
- Brompheniramine, codeine, and phenylephrine-Insulin Glulisine (Vials)
- Brompheniramine, codeine, and phenylephrine-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Brompheniramine, Codeine, and Phenylephrine Liquid
- Insulin glargine and lixisenatide-Brompheniramine, codeine, and pseudoephedrine
- Insulin glargine and lixisenatide-Brompheniramine, dextromethorphan, and phenylephrine
- Insulin glargine and lixisenatide-Brompheniramine, dextromethorphan, and pseudoephedrine
- Insulin glargine and lixisenatide-Brompheniramine, dextromethorphan, guaifenesin, and phenylephrine
- Insulin glargine and lixisenatide-Brompheniramine, hydrocodone, and pseudoephedrine